$XLRN ACCELERON PHARMA INC Insider Trading Week 16/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 16/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 31.45 | 48,713 | 1,532,024 | 72,759 | 121.5 K to 72.8 K (-40.10 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 31.45 | 805,905 | 25,345,712 | 1,203,720 | 2 M to 1.2 M (-40.10 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 33.81 | 1,351 | 45,677 | 121,472 | 122.8 K to 121.5 K (-1.10 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 33.81 | 22,349 | 755,620 | 2,009,625 | 2 M to 2 M (-1.10 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 35.89 | 6,936 | 248,933 | 122,823 | 129.8 K to 122.8 K (-5.35 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 35.89 | 114,746 | 4,118,234 | 2,031,974 | 2.1 M to 2 M (-5.35 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 0.92 | 2,000 | 1,840 | 25,500 | |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 36.13 | 500 | 18,065 | 0 | 500 to 0 (-100.00 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 35.75 | 1,500 | 53,625 | 500 | 2 K to 500 (-75.00 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 14,375 | |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.17 | 700 | 25,319 | 27,656 | 28.4 K to 27.7 K (-2.47 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 35.75 | 1,800 | 64,350 | 28,356 | 30.2 K to 28.4 K (-5.97 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 30,156 | 27.7 K to 30.2 K (+9.04 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 35.86 | 2,000 | 71,720 | 45,890 | 47.9 K to 45.9 K (-4.18 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 35.75 | 1,000 | 35,750 | 36,500 | 37.5 K to 36.5 K (-2.67 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 36.08 | 1,936 | 69,851 | 15,922 | 17.9 K to 15.9 K (-10.84 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 35.64 | 2,064 | 73,561 | 17,858 | 19.9 K to 17.9 K (-10.36 %) |